ATYR1940
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ATYR1940, covering 2021-08-11 to 2023-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]